MedTrace Logo

Open-Label Placebo for Functional Dyspepsia

NCT03745781 · Status: TERMINATED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2020-05-06

No results posted yet for this study

Summary

The study is evaluating the efficacy of open-label placebo for the treatment of functional dyspepsia.

Conditions

  • Dyspepsia

Interventions

DRUG

Placebos

placebo pills

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-01
Primary Completion
2019-10-07
Completion
2019-10-07

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03745781 on ClinicalTrials.gov